Back
Bristol-Myers Squibb Vs. Merck & Industry Stock Comparison
Buy
51
BMY
Bristol-Myers Squibb
Last Price:
57.66
Seasonality Move:
1.66%
Sell
25
MRK
Merck &
Last Price:
100.07
Seasonality Move:
1.97%
Buy
51
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $57.65. The Score for BMY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
- The current Merck & [MRK] share price is $100.06. The Score for MRK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $57.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRK Stock Price Chart
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 52.31 | Buy |
| Chaikin Money Flow: | 12636972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.95 - 59.25) | Sell |
| Bollinger Bands (100): | (48.66 - 56.56) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 44.76 | Sell |
| Chaikin Money Flow: | -385938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.31 | Buy |
| 20-day SMA: | 58.18 | Sell |
| 50-day SMA: | 55.88 | Buy |
| 200-day SMA: | 49.15 | Buy |
| 8-day EMA: | 57.16 | Buy |
| 20-day EMA: | 57.45 | Buy |
| 50-day EMA: | 55.85 | Buy |
| 200-day EMA: | 51.88 | Buy |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.38 | Sell |
| 20-day SMA: | 100.95 | Sell |
| 50-day SMA: | 102.99 | Sell |
| 200-day SMA: | 118.36 | Sell |
| 8-day EMA: | 100.99 | Sell |
| 20-day EMA: | 101.25 | Sell |
| 50-day EMA: | 103.78 | Sell |
| 200-day EMA: | 112.73 | Sell |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.48 per share, and an increase next year of $6.16 per share.
Merck & Earnings Growth & MRK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.37 per share, and an increase next year of $1.77 per share.
Bristol-Myers Squibb Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||